{"id":"https://openalex.org/W4283333285","doi":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","title":"P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTR\u00d6M MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY","display_name":"P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTR\u00d6M MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283333285","doi":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9431287"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000847388.33116.c7","doi":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021799289","display_name":"R. G. Owen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R. Owen","raw_affiliation_strings":["St. James\u2019s University Hospital, Leeds"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. James\u2019s University Hospital, Leeds","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032707318","display_name":"H. McCarthy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799967250","display_name":"Royal Bournemouth Hospital","ror":"https://ror.org/01v14jr37","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799967250","https://openalex.org/I4387155041"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. McCarthy","raw_affiliation_strings":["Royal Bournemouth Hospital, Bournemouth"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Bournemouth Hospital, Bournemouth","institution_ids":["https://openalex.org/I2799967250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059022907","display_name":"Simon A. Rule","orcid":"https://orcid.org/0000-0001-8937-6351","observed_orcids":["https://orcid.org/0000-0001-8937-6351"]},"institutions":[{"id":"https://openalex.org/I4210149652","display_name":"AstraZeneca (Canada)","ror":"https://ror.org/04n8fbz89","country_code":"CA","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210149652"]},{"id":"https://openalex.org/I897542642","display_name":"University of Plymouth","ror":"https://ror.org/008n7pv89","country_code":"GB","type":"education","lineage":["https://openalex.org/I897542642"]}],"countries":["CA","GB"],"is_corresponding":false,"raw_author_name":"S. Rule","raw_affiliation_strings":["AstraZeneca, Mississauga, Ontario, Canada","Plymouth University Medical School, Plymouth, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Mississauga, Ontario, Canada","institution_ids":["https://openalex.org/I4210149652"]},{"raw_affiliation_string":"Plymouth University Medical School, Plymouth, United Kingdom","institution_ids":["https://openalex.org/I897542642"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013365708","display_name":"Shirley D\u2019Sa","orcid":"https://orcid.org/0000-0003-0840-3499","observed_orcids":["https://orcid.org/0000-0003-0840-3499"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. D\u2019Sa","raw_affiliation_strings":["University College London Hospitals NHS Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London Hospitals NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064745168","display_name":"S. Thomas","orcid":"https://orcid.org/0009-0008-8199-0726","observed_orcids":["https://orcid.org/0009-0008-8199-0726"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Thomas","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070068862","display_name":"O. Tournilhac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]},{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"O. Tournilhac","raw_affiliation_strings":["University of Southampton Hospital Trust, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southampton Hospital Trust, Southampton, United Kingdom","institution_ids":["https://openalex.org/I2802965805","https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078295579","display_name":"Francesco Forconi","orcid":"https://orcid.org/0000-0002-2211-1831","observed_orcids":["https://orcid.org/0000-0002-2211-1831"]},"institutions":[{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]},{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F. Forconi","raw_affiliation_strings":["University of Southampton Hospital Trust, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southampton Hospital Trust, Southampton, United Kingdom","institution_ids":["https://openalex.org/I2802965805","https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036293139","display_name":"Marie Jos\u00e9 Kersten","orcid":"https://orcid.org/0000-0002-8904-3802","observed_orcids":["https://orcid.org/0000-0002-8904-3802"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Jos\u00e9 Kersten","raw_affiliation_strings":["Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4387152927","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091882595","display_name":"Pier Luigi Zinzani","orcid":"https://orcid.org/0000-0002-2112-2651","observed_orcids":["https://orcid.org/0000-0002-2112-2651"]},"institutions":[{"id":"https://openalex.org/I4210117483","display_name":"Istituto di Ematologia di Bologna","ror":"https://ror.org/01mze9517","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210117483"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Luigi Zinzani","raw_affiliation_strings":["Institute of Hematology University of Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Hematology University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I4210117483","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038473213","display_name":"Sunil Iyengar","orcid":"https://orcid.org/0000-0003-4863-4160","observed_orcids":["https://orcid.org/0000-0003-4863-4160"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Iyengar","raw_affiliation_strings":["Royal Marsden Hospital, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital, London","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103541706","display_name":"Jaimal Kothari","orcid":"https://orcid.org/0009-0003-2807-823X","observed_orcids":["https://orcid.org/0009-0003-2807-823X"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Kothari","raw_affiliation_strings":["Churchill Hospital, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Churchill Hospital, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049413660","display_name":"Monique C. Minnema","orcid":"https://orcid.org/0000-0002-3139-8379","observed_orcids":["https://orcid.org/0000-0002-3139-8379"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Minnema","raw_affiliation_strings":["University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands; on behalf of the Lunenburg Lymphoma Phase I/II Consortium \u2013 HOVON/LLPC, Utrecht, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands; on behalf of the Lunenburg Lymphoma Phase I/II Consortium \u2013 HOVON/LLPC, Utrecht, Netherlands","institution_ids":["https://openalex.org/I193662353","https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018522443","display_name":"Efstathios Kastritis","orcid":"https://orcid.org/0000-0001-8191-5832","observed_orcids":["https://orcid.org/0000-0001-8191-5832"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"E. Kastritis","raw_affiliation_strings":["National and Kapodistrian University of Athens, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National and Kapodistrian University of Athens, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082606841","display_name":"Bruce D. Cheson","orcid":"https://orcid.org/0000-0001-9255-7655","observed_orcids":["https://orcid.org/0000-0001-9255-7655","https://orcid.org/0000-0002-6246-4308"]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Cheson","raw_affiliation_strings":["Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, United States of America","institution_ids":["https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026821034","display_name":"Harriet S. Walter","orcid":"https://orcid.org/0000-0003-2618-711X","observed_orcids":["https://orcid.org/0000-0003-2618-711X"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. Walter","raw_affiliation_strings":["Ernest and Helen Scott Haematological Research Institute and Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ernest and Helen Scott Haematological Research Institute and Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081100938","display_name":"D. Greewald","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Greewald","raw_affiliation_strings":["Cancer Center of Santa Barbara, Santa Barbara"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center of Santa Barbara, Santa Barbara","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Calvo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Calvo","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007294135","display_name":"C.-C. Wun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.-C. Wun","raw_affiliation_strings":["AstraZeneca, South San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, South San Francisco","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075465142","display_name":"R. Furman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Furman","raw_affiliation_strings":["Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, United States of America","institution_ids":["https://openalex.org/I1340179700"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":23,"corresponding_author_ids":["https://openalex.org/A5021799289"],"corresponding_institution_ids":["https://openalex.org/I2801331674"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"1020","last_page":"1021"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11899","display_name":"Brucella: diagnosis, epidemiology, treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acalabrutinib","display_name":"acalabrutinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/waldenstrom-macroglobulinemia","display_name":"Waldenstr\u00f6m macroglobulinemia","score":1.0},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.875},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8799999952316284},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.8420000076293945},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7649999856948853},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6029999852180481},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.37400001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7376622557640076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6847645044326782},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6368246078491211},{"id":"https://openalex.org/C2781038049","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Waldenstrom macroglobulinemia","level":3,"score":0.604695737361908},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5580337047576904},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4954577684402466},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.4670713543891907},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4628739655017853},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4520367383956909},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4441564679145813},{"id":"https://openalex.org/C2776391228","wikidata":"https://www.wikidata.org/wiki/Q4118092","display_name":"Macroglobulinemia","level":3,"score":0.4371337592601776},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4324914515018463},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4212755858898163},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4125174582004547},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.38404279947280884},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.351643443107605},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3266937732696533},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.29512932896614075},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.28213226795196533},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2050040066242218},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.17051175236701965},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.14375218749046326},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.13100308179855347},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.11899518966674805},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.06377643346786499},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000847388.33116.c7","doi":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9431287","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9431287/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:e6f75c206efb4b95b56fedbea92efbae","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e6f75c206efb4b95b56fedbea92efbae","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 1020-1021 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000847388.33116.c7","doi":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847388.33116.c7","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2890429531","https://openalex.org/W2995503228","https://openalex.org/W7154456763","https://openalex.org/W4405049126","https://openalex.org/W3199959099","https://openalex.org/W4379981977","https://openalex.org/W4310106124","https://openalex.org/W4301396684","https://openalex.org/W7163350970","https://openalex.org/W2996079902"],"abstract_inverted_index":{"Background:":[0],"Bruton":[1],"tyrosine":[2],"kinase":[3],"(BTK)":[4],"inhibitors":[5],"are":[6,183,433],"effective":[7,467],"in":[8,31,37,56,240,248,274,283,369,377,394,401,412,419,435,448,478],"the":[9,50,85,160,241,249,275,284,287,340,360,370,378,395,402,413,420,436,449],"treatment":[10,468],"of":[11,44,54,71,88,144,179,227,430],"Waldenstr\u00f6m":[12,166],"macroglobulinemia":[13],"(WM).":[14],"Acalabrutinib":[15,463],"is":[16,464],"a":[17,32,79,177,225,302,465,474],"highly":[18,466],"selective,":[19],"potent,":[20],"covalent":[21],"BTK":[22],"inhibitor":[23],"that":[24,469],"demonstrated":[25],"less":[26],"toxicity":[27],"and":[28,52,153,181,196,244,261,278,296,314,329,342,354,373,405,427,445,451],"improved":[29],"tolerability":[30],"head-to-head":[33],"trial":[34,46],"versus":[35],"ibrutinib":[36],"chronic":[38],"lymphocytic":[39],"leukemia.":[40],"Aims:":[41],"The":[42,130,381,423],"aim":[43],"this":[45,89,93],"was":[47,102,133,202,215,234,268,291,309,324,337,349,459],"to":[48,125],"determine":[49],"efficacy":[51],"safety":[53,476],"acalabrutinib":[55,114,120,386],"patients":[57,104,180,189,361,393,400,418,447,479],"with":[58,105,191,221,473,480],"treatment-naive":[59],"(TN)":[60],"or":[61,107,482],"relapsed/refractory":[62],"(R/R)":[63],"WM.":[64,484],"Interim":[65],"results":[66,87],"at":[67],"25":[68],"months":[69],"(mo)":[70],"median":[72,81,200,212,226,304,306],"follow-up":[73],"have":[74],"been":[75],"previously":[76],"reported.":[77,185],"At":[78,301],"5-year":[80],"follow-up,":[82,305],"we":[83],"report":[84],"final":[86],"trial.":[90],"Methods:":[91],"In":[92],"single-arm,":[94],"multicenter,":[95],"phase":[96],"2":[97,228],"trial,":[98],"after":[99],"informed":[100],"consent":[101],"obtained,":[103],"TN":[106,195,242,276,341,371,396,414,452,481],"R/R":[108,222,250,285,343,379,403,421,450,483],"WM":[109],"received":[110],"100":[111,126],"mg":[112,119,127],"oral":[113],"twice":[115,128],"daily":[116],"(or":[117],"200":[118],"once":[121],"daily,":[122],"later":[123],"switched":[124],"daily).":[129],"primary":[131],"endpoint":[132],"investigator-assessed":[134],"overall":[135,150],"response":[136,145,253],"rate":[137,308,323,336,348],"(ORR).":[138],"Key":[139],"secondary":[140],"endpoints":[141],"included":[142],"duration":[143],"(DOR),":[146],"progression-free":[147],"survival":[148,151],"(PFS),":[149],"(OS),":[152],"safety.":[154],"Efficacy":[155],"parameters":[156],"were":[157,174,194,198,257,368,376,387,439],"based":[158],"on":[159,165,364],"modified":[161],"3rd":[162],"International":[163],"Workshop":[164],"Macroglobulinemia":[167],"(IWWM)":[168],"criteria":[169],"(Kimby":[170],"2006).":[171],"Mutation":[172],"data":[173],"available":[175],"for":[176,339,384],"minority":[178],"therefore":[182],"not":[184,269],"Results:":[186],"Of":[187,359],"106":[188],"treated":[190],"acalabrutinib,":[192],"14":[193],"92":[197],"R/R;":[199],"age":[201],"69":[203],"years":[204],"(range":[205,218,231],"39\u201390);":[206],"94%":[207],"had":[208,224],"ECOG":[209],"PS":[210],"\u22641;":[211],"serum":[213],"IgM":[214],"3615":[216],"mg/dL":[217],"291\u20139740).":[219],"Patients":[220],"disease":[223,407],"prior":[229],"therapies":[230],"1\u20137).":[232],"ORR":[233],"93%":[235],"(95%":[236],"CI:":[237],"66,":[238],"100)":[239],"cohort":[243,277,372],"95%":[245],"(88,":[246],"98)":[247],"cohort;":[251,286],"major":[252],"rates":[254],"(\u2265partial":[255],"response)":[256],"79%":[258],"(49,":[259],"95)":[260],"82%":[262],"(72,":[263],"89),":[264],"respectively.":[265],"Median":[266,334],"DOR":[267,290],"estimable":[270],"(NE)":[271],"(12,":[272],"NE)":[273,282,313],"65":[279],"mo":[280,316],"(55,":[281],"estimated":[288,320,345],"66-mo":[289,321,346],"90%":[292],"(TN;":[293,311,326,351],"47,":[294],"99)":[295,353],"45%":[297],"(R/R;":[298,317,331,356],"27,":[299],"61).":[300],"63.7-mo":[303],"PFS":[307,322],"NE":[310,338],"19,":[312],"68":[315],"53,":[318],"NE);":[319],"84%":[325],"48,":[327],"96)":[328],"52%":[330],"39,":[332],"63).":[333],"OS":[335,347],"cohorts;":[344],"91%":[350],"51,":[352],"71%":[355],"60,":[357],"80).":[358],"who":[362],"remained":[363],"treatment,":[365],"7":[366],"(50%)":[367],"43":[374],"(47%)":[375],"cohort.":[380],"main":[382],"reasons":[383],"discontinuing":[385],"adverse":[388],"events":[389,429],"(AEs)":[390],"(4":[391],"[29%]":[392],"cohort,":[397,415],"15":[398],"[16%]":[399],"cohort)":[404],"progressive":[406],"(PD)":[408],"(1":[409],"[7%]":[410],"patient":[411],"20":[416],"[22%]":[417],"cohort).":[422],"most":[424],"common":[425],"AEs":[426,443],"selected":[428],"clinical":[431],"interest":[432],"listed":[434],"Table.":[437],"There":[438],"12":[440],"grade":[441],"5":[442],"(11":[444],"1":[446,455],"cohorts,":[453],"respectively);":[454],"(intracranial":[456],"hematoma":[457],"[R/R])":[458],"considered":[460],"treatment-related.":[461],"Image:Summary/Conclusion:":[462],"achieved":[470],"durable":[471],"responses":[472],"favorable":[475],"profile":[477]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-06-24T00:00:00"}